FDA issues EUAs for ventilator devices, surgical masks

Aug 07, 2020 - 02:41 PM
FDA product update

The Food and Drug Administration Tuesday authorized the emergency use of three types of ventilator accessories for treating COVID-19 patients.

The Lombardi Undersea subsalve oxygen treatment hood is a patient interface for helmet-based non-invasive positive pressure ventilation; a valve from VORTRAN Medical Technology 1 Inc. provides constant-flow pressure-cycled ventilator support; and a device from Nanotronics Imagining Inc. provides bi-level positive air pressure support.

FDA on Wednesday also issued an umbrella emergency use authorization to meet supply demands for certain disposable, single-use surgical masks that meet performance requirements for use in health care settings to provide a physical barrier to fluids and particulate materials to prevent exposure to respiratory droplets and large particles.

Related News Articles

Headline
HHS to end emergency authorization for COVID-19 drugs, medical devices 
The Department of Health and Human Services June 30 announced it will terminate emergency use authorization declarations for certain drugs and medical devices…
Headline
CMS Administrator Oz and Deputy Administrator Brillman discuss agency’s focus on innovation, reducing waste
Centers for Medicare & Medicaid Services Administrator Mehmet Oz, M.D., and CMS Deputy Administrator and Director of Medicaid and CHIP Dan Brillman sat…
Headline
CDC releases report on flu, COVID-19 vaccination coverage for health care workers for 2024-25 respiratory season 
Flu and COVID-19 vaccination rates among all health care workers for the 2024-25 respiratory virus season was 76.3% and 40.2%, respectively, according to a…
Headline
Study estimates more than 155,000 uncounted COVID-19 deaths occurred early during pandemic 
A study published March 18 by Science Advances estimated that more than 155,000 U.S. COVID-19 deaths were uncounted during the COVID-19 pandemic. Researchers…
Headline
CDC report highlights low use of COVID-19 antivirals among people 65 and older 
The Centers for Disease Control and Prevention Feb. 19 released a report on the low use of COVID-19 antiviral drugs among individuals age 65 and older, a…
Headline
FDA issues guidance on wellness products, clinical decision support software
The Food and Drug Administration today released two guidance documents; one related to low-risk wellness products (including certain wearable devices) and the…